Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 298, pseudogene (RNU6-298P) is a genomic pseudogene corresponding to the highly conserved U6 small nuclear RNA gene, but it does not encode a functional product[4][7]. U6 small nuclear RNA itself is a critical component of the spliceosome, involved in intron removal during mRNA splicing[1][3][5], but RNU6-298P is one of many fragmented, nonfunctional copies dispersed through the human genome that serve as evolutionary remnants rather than active participants in cellular processes. Pseudogenes like RNU6-298P generally have no protein product and are not implicated as therapeutic targets, disease markers, or mechanistic entities. In rare cases, pseudogenes may have regulatory roles or be transcribed, but there is no evidence for RNU6-298P having such activity[4][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 298, pseudogene (RNU6-298P).